MOSAPRIDE

SynDRA canonical compound SYN0002792 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	HTR4
Mechanism of action	Serotonin receptor agonist
Indication	dyspepsia \| gastroesophageal reflux disease (GERD) \| hypertrophic gastritis (GHG) \| irritable bowel syndrome
Disease area	gastroenterology

All known targets

gasmotin
AS-4370
mosapride citrate hydrate
mosapride citrate
mosapride citrate dihydrate
Mosaprida
Mosart
4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide
Mosapride [INN]
CHEMBL60889
Mosapride (INN)
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide
AK-41276
4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide
Q-201413
4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide
mosaprida
I8MFJ1C0BY
CHEBI:94373
CHEBI:167204
mosapridum
RefChem:159818
DTXCID4028381
A03FA09
C21H25ClFN3O3
MFCD00867430
UNII-I8MFJ1C0BY
Mosapid
Mosid-MT
Mosart (TN)
MOSAPRIDE [MI]
MOSAPRIDE [WHO-DD]
SCHEMBL16417
GTPL242
MLS004774042
cid_119583
orb1299196
SCHEMBL29400580